Answers are grounded in this paper and cite their sources.
Clinical perspective highlights emerging oral complications of tirzepatide in dental patients, suggesting oral medicine practitioners routinely screen for dual incretin therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Miranda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: